Objective
The overall objective of this study is to determine the pooled prevalence of road traffic injuries, patterns, predictors, and outcomes of road traffic accidents in Nigeria.
Specific Objectives
- To determine the pooled prevalence of road traffic injuries in Nigeria.
- To deterime the summary prevalence of road traffic accidents in Nigeria.
- To delineate the patterns of RTA in Nigeria
- To ascertain the predictors of RTA in Nigeria.
- To assess the outcomes of RTA in Nigeria.
Review Questions
Specific questions to be answered by this review include:
- What is the pooled prevalence of road traffic injuries (RTI) in Nigeria?
- What is the pooled prevalence of RTAs in Nigeria?
- What are the patterns of RTA in Nigeria?
- What are the predictors of RTA in Nigeria?
- What are the outcomes of RTA in Nigeria?
Design: This is a protocol designed for a consistent and accurate systematic review and meta-analysis of road traffic accidents in Nigeria using observational studies published from 1988 to 2020.
Inclusion criteria are
- Observational studies e.g cross-sectional studies, cohort studies, case control studies and historical cohort studies
- Study must report primary outcome, which is the prevalence of road traffic injuries in Nigeria.
- Secondary outcomes: patterns, predictors and outcomes of RTAs in Nigeria
- Study must be retrievable in the English Language.
- Studies that are available in electronic databases and Grey Literature
Exclusion criteria are
- Letters to editors, narrative reviews, commentaries and editorials.
- duplicates of same studies,
- studies that are not retrievable in English language
PICOs
Participants: People in Nigeria involved in RTA
Intervention: None
Comparator: None
Outcomes (Measurable Outcome): The primary outcome is proportion of road traffic injuries in Nigeria.
Secondary outcomes: the proportion of road traffic accidents in Nigeria, patterns, predictors; and outcomes of road traffic accidents in Nigeria.
These studies will be reported in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2015.
Information sources
The search will use sensitive topic-based strategies designed for each database. The following databases will be searched: CINAHL, EMBASE, MEDLINE, Cochrane Library and PubMed web of science, google scholar, African journal online and Scopus and annual reports of the Federal Road Safety Corps (Nigeria).
Search strategy
The search strategy will include MeSH terms, text words, and entry terms. The search strategies used for the databases are shown in Table 1.
Data Extraction and Management
a. Data Extraction
Three main tools will be used for data extraction and managment: a) Rayyan QCRI systematic review screening tool, b) Microsoft Excel c)) CMA Version 3 Software
Five levels of data screening will be used for searched studies:
- Level 1: Screening of identified studies based on study characteristics using study design, inclusion and exclusion criteria
- Level 2: Screening of studies based on the titles and abstracts using the search strategy
- Level 3: studies will be screened by reading the full text of articles.
- Level 4: Outcome level: identify primary and secondary outcomes present in identified studies.
- Level 5: Snowballing of literature on references from included studies.
- Level 6: Screening of grey literature
b. Reviewers: Sixteen reviewers are involved in this study. A pair of reviewers will independently screen the search articles of a database for eligibility using Rayyan QCRI systematic review screening tool. It is a blind review. Conflict between the paired reviewers shall be resolved by a third reviewer who would server as a tiebreaker.
c. Selection process
Studies will be deduplicated in Rayyan QCRI. Eligible studies will be selected on the basis of predefined criteria, which includes study characteristics and measurable outcomes. Authors of eligible studies with any missing data will be contacted via email and telephone.
d. Data collection
Data items from eligible studies will be extracted into a predefined template in Microsoft Excel. The data items to be extracted include:
i). Surname of first author and year of publication
ii) Proportion of road traffic injuries in Nigeria
iii) Proportion of road traffic accidents in Nigeria
iv) Geographical location (State in Nigeria)
v) Gender of RTA victims
vi) Age of RTA victims
vii) Patterns of road traffic accidents including types of vehicles and persons involved, e.g motorists, pedestrians, cyclists, horse riders etc.
viii) Predictors of RTA including substance use, speed, age of driver/rider, road conditions, weather conditions, time of the day/night, vehicle road worthiness and road regulations
ix) Accident outcomes: number of deaths, severity and types of injuries sustained, cost of treatment, and length of hospital admission.
Data items (Measurable outcomes)
- Proportion of RTIs and RTAs in Nigeria, the effect size is prevalence
- Geographical distribution of RTA in Nigeria, data is categorical
- RTA related outcomes in Nigeria: number of deaths, severity of injury, cost of treatment and length of hospital stay. They are all numerical variables.
- Patterns of RTA: types of vehicles involved (this is categorical)
- Predictors of RTA: substance use, speed, age, driver/rider, road, weather conditions, time of the day/night, vehicle road worthiness and road regulations. These are categorical.
Risk of bias
The risk of bias for each eligible study will be assessed using the National Institute of Health (NIH) Quality assessment tool for observational cohort and cross-sectional studies. This will be cross-checked with the Cochrane tool of risk of bias assessment. Both NIH Quality scores and the Cochrane ROB (risk of bias) outcome will be reported in a table. Two independent reviewers will do the scoring for the selected studies. Conflicts in scoring will be reviewed by a tiebreaker (a third independent reviewer).
Assessment of Meta-bias
Meta-bias for each study will be assessed as follows:
- Method of reporting RTIs and RTAs at the outcome level.
- Studies reported in different indexes but with similar outcomes and designs will be converted to the primary effect size at the study level using the CMA software version 3.
- Heterogeneity will be assessed at the study level using the CMA software: To test for heterogeneity Cochrane’s Q value and its p value, I², Ʈ² will be used. The effect size to be used is prevalence at 95% confidence Interval (CI, 95%). As a rule of thumb, I² values of less than 40% will be considered low heterogeneity while values > 40 but < 75 % will be considered moderate and values > 75% are high.
- Publication bias will be assessed at the study level using the CMA software.
- Sensitivity test will be performed at the study level using the CMA software.
Data synthesis
Criteria for data synthesis:
- Eligible studies that reported primary outcomes would be included for systematic review.
- Studies with high/critical bias (NIH quality score of < 7, Cochrane ROB outcome of critical bias) will be considered on individual basis for inclusion by using Sensitivity testing on the CMA software.
- Eligible studies that reported primary outcomes with or without secondary outcomes and have acceptable quality score will be included for meta-analysis.
- Quantitative analysis will be done using the Comprehensive Meta-analysis CMA Software Version 3 (BioStat, USA). For each reported prevalence of road traffic injury, standard error, variance and assigned relative weight for each specific eligible study will be calculated by the CMA software.
- Subgroup analysis will be done using several categorical variables including substance use, speed, age, driver/rider, road, weather conditions, time of the day/night, vehicle road worthiness and road regulations.
- Random computational model will be used for the meta-analysis.
- Meta-regression will be performed using quantitative data such as number of deaths, severity of injury, cost of treatment, number RTAs and length of hospital admission as explanatory variables and number of RTIs per annum as outcome variable
- A cumulative meta-analysis for trend will be performed to check for trend if any from 1988 to 2020.
Presentation and Reporting of Results
The study selection process will be summarized in a Prisma flow chart according to the PRISMA 2015 Statement and PRISMA-P Checklist. A table of search strategy in various databases showing text words, MeSH and entry terms will be included. List of included studies will be summarized in a table. Quantitative data such as effect size (prevalence), standard error, variance, 95 % CI, P values, relative weights assigned to studies and heterogeneity tests will be included in the forest plots. A table of quality scores and risk of bias of each eligible study will be included. Forest plots to show sub-group analysis will be presented. Data on patterns, predictors and outcomes of RTAs will be presented in tables and graphs. Regreesion plots and graphs for trend will be presented.